Checkpoint Therapeutics (CKPT) Misses Q2 EPS by 18c

Checkpoint Therapeutics (NASDAQ: CKPT) reported Q2 EPS of ($0.18).

For earnings history and earnings-related data on Checkpoint Therapeutics (CKPT) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Circle board member resigns after nearly 13 years of service
• Nvidia pitches Vera CPU to Chinese clients with August delivery target